Cronos Group Quarterly Income Statement
NASDAQ: CRONHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cronos Group revenue and earnings
In the quarter ended Jun 30, 2026, Cronos Group generated $53.0 million in revenue, up 58.4% from the same quarter a year earlier. Net income was $32.1 million, for a net margin of 60.5% versus a median of 19.0% in the prior 5 quarters. Gross margin was 53.7% (up from 43.4%) and operating margin 14.0%.
Diluted earnings per share came in at $0.09.
Summary generated from market data by MetaCap's automated system. Methodology
Cronos Group income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53.01M | 45.21M | 44.53M | 36.34M | 33.45M | 32.26M | 30.30M | 34.26M | 27.76M | 25.29M | 23.91M | 24.81M |
| Revenue growth (YoY) | +58.44% | +40.13% | +46.96% | +6.06% | +20.51% | +27.58% | +26.70% | +38.11% | +45.95% | +29.72% | +8.54% | +21.56% |
| Gross Profit | 28.45M | 19.15M | 16.19M | 18.33M | 14.50M | 13.73M | 10.81M | 3.61M | 6.30M | 4.48M | 1.91M | 3.97M |
| Operating Expenses | 21.05M | 20.99M | 23.68M | 18.84M | 19.83M | 17.81M | 22.17M | 37.27M | 21.86M | 20.43M | 23.55M | 25.75M |
| Research & Development | 1.22M | 1.41M | 1.38M | 1.34M | 929.00K | 793.00K | 1.03M | 1.24M | 962.00K | 997.00K | 1.45M | 1.25M |
| Selling, General & Admin | 17.59M | 17.35M | 19.45M | 14.55M | 15.88M | 13.87M | 18.49M | 18.29M | 17.10M | 14.24M | 16.17M | 19.66M |
| Operating Income | 7.40M | -1.83M | -7.50M | -503.00K | -5.32M | -4.07M | -11.37M | -33.66M | -15.56M | -15.95M | -21.64M | -21.77M |
| Other Income (Expense) | 28.31M | 19.97M | -4.89M | 27.51M | -33.68M | 11.34M | 57.31M | 38.27M | 4.63M | 12.91M | -23.88M | 18.93M |
| Pretax Income | 35.71M | 18.14M | -12.39M | 27.00M | -39.01M | 7.27M | 45.95M | 4.62M | -10.93M | -3.04M | -45.51M | -2.84M |
| Income Tax | 51.00K | 2.43M | -11.89M | -1.32M | -525.00K | -455.00K | 2.00M | -2.71M | -2.17M | -558.00K | -360.00K | -1.25M |
| Net Income | 32.09M | 13.75M | -1.82M | 25.96M | -39.71M | 6.12M | 43.73M | 8.35M | -8.76M | -2.24M | -44.79M | -1.64M |
| Net Income growth (YoY) | — | +124.63% | -104.15% | +210.91% | — | — | — | — | — | — | — | — |
| EPS (Basic) | 0.09 | 0.04 | -0.01 | 0.07 | -0.10 | 0.02 | 0.12 | 0.02 | -0.02 | -0.01 | -0.12 | 0.00 |
| EPS (Diluted) | 0.09 | 0.04 | -0.01 | 0.07 | -0.10 | 0.02 | 0.12 | 0.02 | -0.02 | -0.01 | -0.12 | 0.00 |
| Shares Outstanding (Basic) | 373.61M | 379.37M | — | 383.09M | 385.31M | 382.96M | — | 382.29M | 382.16M | 381.44M | — | 381.10M |
| Shares Outstanding (Diluted) | 375.06M | 381.80M | — | 384.99M | 385.31M | 386.96M | — | 385.98M | 382.16M | 381.44M | — | 381.10M |
| EBITDA | 10.78M | 1.89M | -3.84M | 3.03M | -1.12M | -1.23M | -8.84M | -30.09M | -14.05M | -14.22M | -20.46M | -19.63M |
| Gross Margin | 53.67% | 42.36% | 36.35% | 50.45% | 43.35% | 42.57% | 35.67% | 10.54% | 22.68% | 17.73% | 8.00% | 16.00% |
| Operating Margin | 13.97% | -4.05% | -16.83% | -138.00% | -15.91% | -12.62% | -37.51% | -98.22% | -56.05% | -63.07% | -90.47% | -87.77% |
| Net Margin | 60.53% | 30.42% | -4.08% | 71.43% | -118.70% | 18.98% | 144.32% | 24.37% | -31.54% | -8.86% | -187.29% | -6.63% |
This table shows 12 quarterly periods of Cronos Group's income statement, from Q2 2026 back to Q3 2023, across 19 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow CRON's reporting calendar. What is a income statement?